Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2022 Nov 21;11(22):6869.
doi: 10.3390/jcm11226869.

Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus

Christopher Sjöwall  1 , Ioannis Parodis  2   3
Affiliations
Editorial

Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus

Christopher Sjöwall et al. J Clin Med. .

Abstract

The clinical presentation of systemic lupus erythematosus (SLE) is highly heterogeneous, ranging from mild disease limited to skin and joint involvement to life-threatening conditions with renal impairment, severe cytopenias, central nervous system disease, and thromboembolic events [...].

PubMed Disclaimer

Conflict of interest statement

C.S. declares no conflict of interest related to this work. I.P. has received research funding and/or honoraria from Amgen, AstraZeneca, Aurinia Pharmaceuticals, Elli Lilly and Company, Gilead Sciences, GlaxoSmithKline, Janssen Pharmaceuticals, Novartis and F. Hoffmann-La Roche AG. The funders had no role in the design of the study, the analyses or interpretation of data, or the writing of the manuscript.

References

    1. Kaul A., Gordon C., Crow M.K., Touma Z., Urowitz M.B., van Vollenhoven R., Ruiz-Irastorza G., Hughes G. Systemic lupus erythematosus. Nat. Rev. Dis. Prim. 2016;2:16039. doi: 10.1038/nrdp.2016.39. - DOI - PubMed
    1. Gomez A., Qiu V., Cederlund A., Borg A., Lindblom J., Emamikia S., Enman Y., Lampa J., Parodis I. Adverse Health-Related Quality of Life Outcome Despite Adequate Clinical Response to Treatment in Systemic Lupus Erythematosus. Front. Med. 2021;8:651249. doi: 10.3389/fmed.2021.651249. - DOI - PMC - PubMed
    1. Björk M., Dahlström Ö., Wetterö J., Sjöwall C. Quality of life and acquired organ damage are intimately related to activity limitations in patients with systemic lupus erythematosus. BMC Musculoskelet. Disord. 2015;16:188. doi: 10.1186/s12891-015-0621-3. - DOI - PMC - PubMed
    1. Jung J.-Y., Lee H.-Y., Lee E., Kim H.-A., Yoon D., Suh C.-H. Three Clinical Clusters Identified through Hierarchical Cluster Analysis Using Initial Laboratory Findings in Korean Patients with Systemic Lupus Erythematosus. J. Clin. Med. 2022;11:2406. doi: 10.3390/jcm11092406. - DOI - PMC - PubMed
    1. Mahler M., Bentow C., Aure M.-A., Fritzler M.J., Satoh M. Significance of Autoantibodies to Ki/SL as Biomarkers for Systemic Lupus Erythematosus and Sicca Syndrome. J. Clin. Med. 2022;11:3529. doi: 10.3390/jcm11123529. - DOI - PMC - PubMed

Publication types

LinkOut - more resources